ClinicalTrials.Veeva

Menu

The Effects of a Personalized Sleep Improvement App From SleepScore Labs

ResMed logo

ResMed

Status

Enrolling

Conditions

Health Behavior

Treatments

Behavioral: Dein Schlaf. Dein Tag. sleep improvement application powered by SleepScore

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT05195359
20211202DSDT

Details and patient eligibility

About

The study is a single-blinded randomized waitlist controlled trial that aims to assess changes in objective and self-report sleep improvement through use of a dynamic and personalized sleep improvement smartphone app and advice engine in those with poor sleep (i.e., subclinical threshold insomnia) when compared to a waitlist control group after 6 weeks and 12 weeks.

Full description

Subclinical sleep dysfunction has a multitude of causes (e.g., environmental, cognitive, behavioral, or physiological) and symptoms (e.g., long sleep onset latency, short sleep duration, elevated wake after sleep onset and nighttime awakenings, poor sleep quality). A personalized and dynamic sleep improvement intervention tailored to an individual's lifestyle and specific needs may therefore be required to help nudge those with poor sleep towards sleep-promoting behaviors and attitudes. Digital and mobile health platforms are also highly scalable and cost-effective, thus allowing for widespread implementation across larger subclinical populations.

The purpose of the present study is to conduct a single-blinded randomized waitlist controlled trial to evaluate a novel smartphone application, Dein Schlaf. Dein Tag. powered by SleepScore, designed to both objectively measure and improve sleep. The Dein Schlaf. Dein Tag. app features a validated sonar sleep measurement tool and also provides dynamic and personalized sleep advice founded in the principles of cognitive behavioral psychology and sleep hygiene, offering a non-invasive and non-pharmacological behavioral intervention designed to improve sleep and circadian functioning in those with common sleeping difficulties. Participants will be randomly assigned to the sleep improvement app intervention or a waitlist control group. Online assessments on validated sleep and preventative health measures will take place at baseline, 6 weeks, and 12 weeks.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • iOS user
  • Sub-clinical threshold insomnia symptoms (Regensburg Insomnia Scale Score 13-24)
  • ≥ 18 years old.
  • Naive to the SleepScore Labs App
  • Able to fully understand information on data protection and provide written informed consent

Exclusion criteria

  • Non-iOS device users due to technical restrictions of the application

  • Bedtime less than 6 hours

  • Any of the following medical problems:

    • Untreated psychological disorder affecting sleep (e.g., depression, anxiety disorders, bipolar disorder, schizophrenia)
    • Current severe medical conditions (e.g. chronic pain, cancer)
  • Any of the following medications/substance use:

    • Prescription sleep medications or regular use of over-the-counter sleep medications
    • Medication for other conditions (e.g., anxiety, ADHD) that affect sleep, e.g. antidepressants, antipsychotics
  • Consumption of 3+ units of alcohol on 4 or more nights per week

  • Recreational or nightly drug use

  • Pregnant or nursing mothers

  • Shift work

  • Travel across 2 or more time zones during study period

  • Sleeping more than 7 nights not at home during study period

  • Users who newly received a diagnosis of a sleep disorders

  • Users who start sleep or other psychoactive medication during the study period

  • Use of other Sleep Tracking App's during the study period

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

600 participants in 2 patient groups

Allocation to Sleep Improvement App
Active Comparator group
Description:
Participants will be instructed to engage with the Dein Schlaf. Dein Tag. smartphone app, log their behaviors in-app, and track their sleep daily for the duration of the study (12 weeks). Participants will be instructed to start the sleep tracking device via their iOS device before lying down in bed and turning off the lights to go to sleep. In the morning, participants will turn off the sleep tracking device as soon as they wake up and decide to leave the bed. At the three time points (baseline, 6 weeks, and 12 weeks), participants will be instructed to complete online assessments on self-reported sleep quality, health perception, psychosocial factors and sleep-permissive behaviors (i.e., preventative health)
Treatment:
Behavioral: Dein Schlaf. Dein Tag. sleep improvement application powered by SleepScore
Allocation to Waitlist Control Group
No Intervention group
Description:
At the three time points (baseline, 6 weeks, and 12 weeks) participants assigned to the wait-list control group will be instructed to complete online assessments on self-reported sleep quality, health perception, psychosocial factors and sleep-permissive behaviors (i.e., preventative health)

Trial contacts and locations

1

Loading...

Central trial contact

Elie Gottlieb, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems